Annual CFF
$36.17M$37.78M+2,342.28%
Summary
- Current Value
- As of today, XERS annual cash from financing is $36.17M, up +2342.28% on
- Historical Performance
- XERS annual cash from financing is up +32.74% over the past 3 years, and down -55.09% over the past 5 years
- All-Time High Comparison
- XERS annual cash from financing is currently -71.79% below its historical high of $128.21M set on
- 3-Year Low Comparison
- XERS annual cash from financing is +2342.28% above its 3-year low of -$1.61M reached on
- Sector Comparison
- XERS annual cash from financing is higher than 71.19% of companies in Healthcare sector
Cash From Financing Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | $36.17M | +2342.3% | +32.7% | -55.1% | +826.4% | |
| Quarterly Cash From Financing | $13.85M | +10000.0% | +7506.4% | +6.0% | +3863.6% | |
| TTM Cash From Financing | $12.05M | -66.3% | -84.6% | -90.3% | +3375.3% | |
| Price | $7.21 | +115.2% | +586.7% | +24.3% | – | |
| Annual Cash From Operations | -$36.98M | +21.4% | +61.3% | +64.6% | -129.9% | |
| Annual Cash From Investing | $4.88M | +181.3% | -95.0% | +304.9% | +10000.0% | |
| Annual Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual Total Debt | $271.45M | +18.4% | +208.2% | +365.6% | +100.0% | |
| Shares Outstanding | 165.92M | +11.0% | +21.8% | +178.3% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $127.47M | N/A | -71.6% |
| 5Y | $127.47M | -71.6% | |
| All | $128.21M | -71.8% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$1.61M | +2342.3% | |
| 5Y | -$1.61M | +2342.3% | |
| All | -$1.61M | +2342.3% |
Cash From Financing History
| Year | Value | Change |
|---|---|---|
| $36.17M | +2,342.3% | |
| -$1.61M | -101.3% | |
| $127.47M | +367.8% | |
| $27.25M | -78.4% | |
| $126.06M | +56.5% |
| Year | Value | Change |
|---|---|---|
| $80.53M | -37.2% | |
| $128.21M | +264.9% | |
| $35.14M | +800.1% | |
| $3.90M | - |
FAQ
What is the current annual cash from financing of XERS?
As of today, XERS annual cash from financing is $36.17M
What is 1-year change in XERS annual cash from financing?
XERS annual cash from financing is up +2342.28% year-over-year
What is 3-year change in XERS annual cash from financing?
XERS annual cash from financing is up +32.74% over the past 3 years
How far is XERS annual cash from financing from its all-time high?
XERS annual cash from financing is currently -71.79% below its historical high of $128.21M set on December 31, 2018
How does XERS annual cash from financing rank versus sector peers?
XERS annual cash from financing is higher than 71.19% of companies in Healthcare sector
When is XERS next annual earnings release?
The next annual earnings release for XERS is on
Quarterly CFF
$13.85M$12.91M+1,370.28%
Summary
- Current Value
- As of today, XERS quarterly cash from financing is $13.85M, up +1370.28% on
- Historical Performance
- XERS quarterly cash from financing is up +16786.75% year-over-year, and up +7506.42% over the past 3 years
- All-Time High Comparison
- XERS quarterly cash from financing is currently -84.75% below its historical high of $90.80M set on
- 3-Year Low Comparison
- XERS quarterly cash from financing is +541.50% above its 3-year low of -$3.14M reached on
- Sector Comparison
- XERS quarterly cash from financing is higher than 84.24% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | $13.85M | +1370.3% | +10000.0% | +7506.4% | +6.0% | |
| Annual Cash From Financing | $36.17M | – | +2342.3% | +32.7% | -55.1% | |
| TTM Cash From Financing | $12.05M | +741.1% | -66.3% | -84.6% | -90.3% | |
| Price | $7.21 | -12.9% | +115.2% | +586.7% | +24.3% | |
| Quarterly Cash From Operations | $18.43M | +10000.0% | +321.9% | +203.8% | +208.5% | |
| Quarterly Cash From Investing | -$71.00K | +74.5% | -100.7% | -101.1% | +99.9% | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $257.65M | +0.2% | -4.9% | +86.0% | +115.8% | |
| Shares Outstanding | 165.92M | – | +11.0% | +21.8% | +178.3% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $13.85M | at high | |
| 3Y | $49.16M | N/A | -71.8% |
| 5Y | $78.19M | -82.3% | |
| All | $90.80M | -84.8% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.14M | +541.5% | |
| 3Y | -$3.14M | +541.5% | |
| 5Y | -$3.14M | +541.5% | |
| All | -$3.14M | +541.5% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of XERS?
As of today, XERS quarterly cash from financing is $13.85M
What is XERS quarterly cash from financing most recent change?
XERS quarterly cash from financing was up +1370.28% on September 30, 2025
What is 1-year change in XERS quarterly cash from financing?
XERS quarterly cash from financing is up +16786.75% year-over-year
How far is XERS quarterly cash from financing from its all-time high?
XERS quarterly cash from financing is currently -84.75% below its historical high of $90.80M set on June 30, 2018
How does XERS quarterly cash from financing rank versus sector peers?
XERS quarterly cash from financing is higher than 84.24% of companies in Healthcare sector
When is XERS next earnings release?
The next earnings release for XERS is on
TTM CFF
$12.05M$13.93M+741.12%
Summary
- Current Value
- As of today, XERS TTM cash from financing is $12.05M, up +741.12% on
- Historical Performance
- XERS TTM cash from financing is down -66.26% year-over-year, and down -84.63% over the past 3 years
- All-Time High Comparison
- XERS TTM cash from financing is currently -92.47% below its historical high of $160.16M set on
- 3-Year Low Comparison
- XERS TTM cash from financing is +657.24% above its 3-year low of -$2.16M reached on
- Sector Comparison
- XERS TTM cash from financing is higher than 58.24% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | $12.05M | +741.1% | -66.3% | -84.6% | -90.3% | |
| Annual Cash From Financing | $36.17M | – | +2342.3% | +32.7% | -55.1% | |
| Quarterly Cash From Financing | $13.85M | +1370.3% | +10000.0% | +7506.4% | +6.0% | |
| Price | $7.21 | -12.9% | +115.2% | +586.7% | +24.3% | |
| TTM Cash From Operations | $10.56M | +165.3% | +132.3% | +109.1% | +110.6% | |
| TTM Cash From Investing | $9.65M | -50.9% | -0.8% | -84.4% | +122.1% | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $257.65M | +0.2% | -4.9% | +86.0% | +115.8% | |
| Shares Outstanding | 165.92M | – | +11.0% | +21.8% | +178.3% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $36.17M | N/A | -66.7% |
| 3Y | $127.47M | N/A | -90.5% |
| 5Y | $127.47M | -90.5% | |
| All | $160.16M | -92.5% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$2.16M | +657.2% | |
| 3Y | -$2.16M | +657.2% | |
| 5Y | -$2.16M | +657.2% | |
| All | -$2.16M | +657.2% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of XERS?
As of today, XERS TTM cash from financing is $12.05M
What is XERS TTM cash from financing most recent change?
XERS TTM cash from financing was up +741.12% on September 30, 2025
What is 1-year change in XERS TTM cash from financing?
XERS TTM cash from financing is down -66.26% year-over-year
How far is XERS TTM cash from financing from its all-time high?
XERS TTM cash from financing is currently -92.47% below its historical high of $160.16M set on March 31, 2019
How does XERS TTM cash from financing rank versus sector peers?
XERS TTM cash from financing is higher than 58.24% of companies in Healthcare sector
When is XERS next earnings release?
The next earnings release for XERS is on
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
Data Sources & References
- XERS Official Website www.xerispharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1867096/000186709625000159/0001867096-25-000159-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1867096/000186709625000039/0001867096-25-000039-index.htm
- XERS Profile on Yahoo Finance finance.yahoo.com/quote/XERS
- XERS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xers